IOVA Competitors & Alternatives
Compare Iovance Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
IOVA
Main Stock$4.32
Tradestie Score
56
Market Cap
$799.70M
Revenue Growth
0.4%
Analyst Upside
+103.9%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.18
|
$2.23B | - | 54 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$23.11
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$54.98
|
$2.21B | - | 59 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$23.15
|
$2.18B | - | 55 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.47
|
$2.08B | - | 49 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.88
|
$2.02B | 42.5 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.77
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.86
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.40
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$87.72
|
$1.92B | - | 45 | Compare |
More IOVA Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry